BRVO with CME following cataract surgery
|
|
52 year old female
The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 271 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 242 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 226 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 225 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 231 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 214 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 249 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 243 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 230 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 239 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 219 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 255 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 241 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 231 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 216 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 217 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 229 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 219 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 216 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 238 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 262 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 245 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 253 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 258 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 238 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 219 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 220 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 213 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvu 226 fois51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
(0 votes)
|
|
|
|
|
|
|
52 year old female
The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
